The invention discloses peptides for the treatment and/or prophylaxis of diabetic retinopathy. The peptides of the invention comprise a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) binding sequence and/or an E3 ubiquitin ligase seven in absentia homolog 1 (Siah1) binding sequence and an internalization sequence.